Impact of disease duration on proteomic bioprofile and prognosis in rheumatoid arthritis patients-Reference-Cited by-同舟云学术

Impact of disease duration on proteomic bioprofile and prognosis in rheumatoid arthritis patients

Published:2022-11-24 Issue: Volume: Page:
ISSN:1593-098X
Container-title:Clinical and Experimental Rheumatology
language:en
Short-container-title:

Author:

Brandão Mariana¹,Fonseca Tomás²,Quelhas Costa Rita³,Oliveira José Carlos⁴,Cyrne Carvalho Henrique⁵,Rodrigues Patrícia⁶,Zannad Faiez⁷,Rossignol Patrick⁸,Ferreira Maria Betânia⁹,Ferreira João Pedro¹⁰

Affiliation:

1. Unidade Multidisciplinar de Investigação Biomédica, Instituto de Ciências Biomédicas Abel Salazar, Universidade do Porto; and Unidade de Imunologia Clínica, Centro Hospitalar Universitário do Porto, Portugal. marianabrandao.uic@chporto.min-saude.pt

2. Unidade de Imunologia Clínica, Centro Hospitalar Universitário do Porto, Portugal.

3. Department of Internal Medicine, Centro Hospitalar de Entre o Douro e Vouga, Aveiro, Portugal.

4. Unidade Multidisciplinar de Investigação Biomédica, Instituto de Ciências Biomédicas Abel Salazar, Universidade do Porto; and Clinical Chemistry Service, Centro Hospitalar de Entre o Douro e Vouga, Aveiro, Portugal.

5. Unidade Multidisciplinar de Investigação Biomédica, Instituto de Ciências Biomédicas Abel Salazar, Universidade do Porto; Cardiology Department Centro Hospitalar Universitário do Porto; and Instituto de Ciências Biomédicas Abel Salazar, Porto, Portugal.

6. Unidade Multidisciplinar de Investigação Biomédica, Instituto de Ciências Biomédicas Abel Salazar, Universidade do Porto; and Cardiology Department Centro Hospitalar Universitário do Porto, Portugal.

7. Université de Lorraine, INSERM, Centre d’Investigations Cliniques Plurithématique 1433, CHRU de Nancy, Inserm U1116 F-CRIN INI-CRCT (Cardiovascular and Renal Clinical Trialists), Nancy, France.

8. Université de Lorraine, INSERM, Centre d’Investigations Cliniques Plurithématique 1433, CHRU de Nancy, Inserm U1116 F-CRIN INI-CRCT (Cardiovascular and Renal Clinical Trialists), Nancy, France, and Department of Medical Specialties and Nephrology-Haemodialysis, Princess Grace Hospital, Monaco, and Centre d’Hémodialyse Privé de Monaco, Principauté de Monaco.

9. Unidade Multidisciplinar de Investigação Biomédica, Instituto de Ciências Biomédicas Abel Salazar, Universidade do Porto; and Hospital da Luz Arrábida, Porto, Portugal.

10. Université de Lorraine, INSERM, Centre d’Investigations Cliniques Plurithématique 1433, CHRU de Nancy, Inserm U1116 F-CRIN INI-CRCT (Cardiovascular and Renal Clinical Trialists), Nancy, France, and UnIC@RISE, Department of Surgery and Physiology, Faculty of Medicine of the University of Porto, Portugal.

Publisher

Clinical and Experimental Rheumatology

Subject

Immunology,Immunology and Allergy,Rheumatology

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. N-demethylsinomenine metabolite and its prototype sinomenine activate mast cells via MRGPRX2 and aggravate anaphylaxis;Frontiers in Pharmacology;2024-07-31

2. Knockdown of Galectin-9 alleviates rheumatoid arthritis through suppressing TNF-α-induced activation of fibroblast-like synoviocytes;Biochemical Pharmacology;2024-02